Enfortumab vedotin plus pembrolizumab improved EFS, OS, and pCR rates in MIBC patients ineligible for cisplatin-based chemotherapy. The combination therapy showed a median EFS and OS that were not ...

Patients with muscle-invasive bladder cancer have varied outcomes after cystectomy. Circulating tumor DNA (ctDNA)–based detection of molecular residual disease may identify patients at high risk ...

HER-2 targeted antibody-drug conjugate monotherapy has demonstrated efficacy in the post-chemotherapy setting for ...

On busy days, you may not feel you have the time to sit on a toilet and wait for your bladder to empty, so you “power pee” — you bear down to expel urine faster. “Power peeing is a really common habit ...

EG110A received FDA fast track designation to treat neurogenic detrusor overactivity, a bladder issue common in MS.

A newly filed federal lawsuit alleges that a Minnesota postal worker died after police officers and jail staff ignored clear ...

Thank you for joining call showcasing the Altaviva device, which just secured FDA approval back on September 18. I want to remind everyone that today's event is being recorded, and a replay will be ...

Embrace Gynecology becomes the third IDE clinical study for Hugo RAS in the U.S., demonstrating Medtronic’s commitment to ...

The bladder is easy to overlook—until it starts causing trouble. This small, balloon-like organ in the lower urinary tract quietly stores and releases urine, helping the body eliminate waste and ...

A CORRUPTION CASE INVOLVING SEX ACTS, CASH AND OTHER BENEFITS. NOW, THE FORMER EXECUTIVE DIRECTOR OF NEBRASKA’S LIQUOR CONTROL COMMISSION IS FACING FEDERAL CHARGES. THANK YOU FOR JOINING US. I’M BILL ...

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...